Trump Administration Officially Going After the Abortion Pill

"On Sunday, it will have been 25 years since mifepristone hit the market, a groundbreaking decision that came about because, like most drugs you'd want approved by government standards, the abortion pill was deemed safe and effective. Now, thanks to a gaggle of our nation's top health chiefs, a team of anti-abortion imbeciles, and a junk study looking to unravel the last half-century of progress, the abortion pill could soon be banned."

"On Friday, FDA CommissionerDr. Marty Makary and Secretary of HHS Robert F. Kennedy Jr. wrote a letter confirming they will re-review the medication in response to a letter from 22 Republican AGs who quietly asked the FDA to re-review the pill in July. The FDA's decision comes after a months-long push from Senator Josh Hawley (R-Missouri), who's been busy amplifying a bogus study from the Ethics and Public Policy Center (EPPC), a far-right "think tank.""

"The study is also referenced in Makary and Kennedy's letter, who've ignored that it's essentially a cock-and-bull paper with no peer review, distorted metrics, and published by a nonprofit that has falsely, and baselessly, tied mifepristone to "serious adverse effects." "The concerns you have raised in your letter merit close examination," the FDA letter reads. "This Administration will ensure that women's health is properly protected by thoroughly investigating the circumstances under which mifepristone can be safely dispensed.""

Mifepristone has been available for 25 years after regulators found it safe and effective. FDA Commissioner Marty Makary and HHS Secretary Robert F. Kennedy Jr. announced a re-review of the medication following a July request from 22 Republican attorneys general and sustained pressure from Senator Josh Hawley. Hawley amplified an EPPC study that lacks peer review and uses distorted metrics to allege serious adverse effects. The FDA letter says the raised concerns merit close examination and promises thorough investigation to ensure safe dispensing. The pill's approvals expanded use to 10 weeks in 2016 and telehealth prescribing in 2023.

Read at Jezebel